VARIAN MEDICAL SYSTEMS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2020 12 months to Oct 2, 2020	FY2019 12 months to Sep 27, 2019	FY2018 12 months to Sep 28, 2018	FY2017 12 months to Sep 29, 2017	FY2016 12 months to Sep 30, 2016
Cash flows from operating activities:
Net earnings
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense
Tax benefits from exercises of share-based payment awards
Excess tax benefits from share-based compensation
Depreciation
Amortization of intangible assets
Amortization of intangible assets and inventory step-up
Deferred taxes
Provision to allowance for doubtful accounts
Gain on equity investments, net
Impairment charges
Loss (gain) on equity investments
Loss on hedges related to acquisition-related activities
Write-off of in-process research and development related to acquisition-related activities
Change in fair value of contingent consideration
Other, net
Changes in assets and liabilities, net of effects of acquisitions:
Trade and unbilled receivables
Inventories
Prepaid expenses and other assets
Accounts payable
Accrued liabilities and other long-term liabilities
Deferred revenues

Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property, plant and equipment
Acquisitions, net of cash acquired
Net amounts received from (paid to) deferred compensation plan trust account
(Increase) decrease in restricted cash
Purchase of equity and notes receivable in privately-held companies
Sale of equity investments
Sale of available-for-sale securities
Investment in available-for-sale securities
Loans to CPTC
Purchase of foreign currency option related to acquisition-related activities
Repayment of notes receivables
Issuance of notes receivable
Purchase of senior secured debt
Other, net
Net cash used in investing activities

Cash flows from financing activities:
Repurchases of common stock
Proceeds from issuance of common stock to employees
Excess tax benefits from share-based compensation
Tax withholdings on vesting of equity awards
Cash received from Varex term facility
Cash and cash equivalents received (contributed) to Varex Imaging Corporation
Borrowings under credit facility agreement
Contingent consideration and hold back
Repayments under credit facility agreement
Net borrowings (repayments) under the credit facility agreements with maturities less than 90 days
Repayment of acquired debt
Payment of contingent consideration
Other
Net cash provided by (used in) financing activities

Cash and cash equivalents at end of period
Cash and cash equivalents from discontinued operations
Effects of exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash, cash equivalents and restricted cash at end of period

Comments